PTPN14
Tyrosine-protein phosphatase non-receptor type 14
Also known as: PEZ, PTN14_HUMAN, PTPD2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15678
- Gene
- PTPN14
- Ensembl
- ENSG00000152104
- Chromosome
- 1
- Canonical length
- 1187 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains an N-terminal noncatalytic domain similar to that of band 4.1 superfamily cytoskeleton-associated proteins, which suggested the membrane or cytoskeleton localization of this protein. It appears to regulate lymphatic development in mammals, and a loss of function mutation has been found in a kindred with a lymphedema-choanal atresia. [provided by RefSeq, Sep 2010]
Canonical amino-acid sequenceUniProt
1187 residues, UniProt reviewed canonical sequence.
>Q15678|PTPN14
1 MPFGLKLRRT RRYNVLSKNC FVTRIRLLDS NVIECTLSVE STGQECLEAV AQRLELRETH
61 YFGLWFLSKS QQARWVELEK PLKKHLDKFA NEPLLFFGVM FYVPNVSWLQ QEATRYQYYL
121 QVKKDVLEGR LRCTLDQVIR LAGLAVQADF GDYNQFDSQD FLREYVLFPM DLALEEAVLE
181 ELTQKVAQEH KAHSGILPAE AELMYINEVE RLDGFGQEIF PVKDNHGNCV HLGIFFMGIF
241 VRNRIGRQAV IYRWNDMGNI THNKSTILVE LINKEETALF HTDDIENAKY ISRLFATRHK
301 FYKQNKICTE QSNSPPPIRR QPTWSRSSLP RQQPYILPPV HVQCGEHYSE THTSQDSIFH
361 GNEEALYCNS HNSLDLNYLN GTVTNGSVCS VHSVNSLNCS QSFIQASPVS SNLSIPGSDI
421 MRADYIPSHR HSAIIVPSYR PTPDYETVMR QMKRGILHTD SQSQSLRNLN IINTHAYNQP
481 EDLVYSQPEM RERHPYTVPY GPQGVYSNKL VSPSDQRNPK NNVVPSKPGA SAISHTVSTP
541 ELANMQLQGS HNYSTAHMLK NYLFRPPPPY PRPRPATSTP DLASHRHKYV SGSSPDLVTR
601 KVQLSVKTFQ EDSSPVVHQS LQEVSEPLTA TKHHGTVNKR HSLEVMNSMV RGMEAMTLKS
661 LHLPMARRNT LREQGPPEEG SGSHEVPQLP QYHHKKTFSD ATMLIHSSES EEEEEEAPES
721 VPQIPMLREK MEYSAQLQAA LARIPNKPPP EYPGPRKSVS NGALRQDQAS LPPAMARARV
781 LRHGPAKAIS MSRTDPPAVN GASLGPSISE PDLTSVKERV KKEPVKERPV SEMFSLEDSI
841 IEREMMIRNL EKQKMAGLEA QKRPLMLAAL NGLSVARVSG REENRVDATR VPMDERFRTL
901 KKKLEEGMVF TEYEQIPKKK ANGIFSTAAL PENAERSRIR EVVPYEENRV ELIPTKENNT
961 GYINASHIKV VVGGAEWHYI ATQGPLPHTC HDFWQMVWEQ GVNVIAMVTA EEEGGRTKSH
1021 RYWPKLGSKH SSATYGKFKV TTKFRTDSVC YATTGLKVKH LLSGQERTVW HLQYTDWPDH
1081 GCPEDVQGFL SYLEEIQSVR RHTNSMLEGT KNRHPPIVVH CSAGVGRTGV LILSELMIYC
1141 LEHNEKVEVP MMLRLLREQR MFMIQTIAQY KFVYQVLIQF LQNSRLILocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTPN14 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 18 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 18 nTPM
- skin: 15 nTPM
- breast: 9.9 nTPM
- blood vessel: 9.5 nTPM
- tongue: 9.5 nTPM
- kidney: 7.6 nTPM
Single-cell type
- podocytes: 666 nCPM
- loop of henle epithelial cells: 565 nCPM
- myonuclei: 512 nCPM
- endometrial glandular cells: 434 nCPM
- endometrial ciliated cells: 401 nCPM
- endometrial luminal cells: 351 nCPM
Immune cell
- basophil: 0.2 nTPM
- neutrophil: 0.1 nTPM
- NK-cell: 0.1 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- choroid plexus: 36 nTPM
- thalamus: 17 nTPM
- amygdala: 16 nTPM
- cerebral cortex: 15 nTPM
- hippocampal formation: 15 nTPM
- medulla oblongata: 13 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTPN14.
Disease | AllUniProt
Conditions PTPN14 is implicated in, by any mechanism.
- Choanal atresia and lymphedema (CATLPH) MIM:613611
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 277 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Lymphedema-posterior choanal atresia syndrome
- Esophageal atresia/tracheoesophageal fistula
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.22
- gnomAD missense Z
- 1.68
- DepMap mean gene effect
- 0.13
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- lymphangiogenesis
- negative regulation of cell population proliferation
- protein dephosphorylation
- regulation of protein export from nucleus
Molecular functions
- protein tyrosine phosphatase activity
- receptor tyrosine kinase binding
- transcription coregulator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Tyrosine-specific protein phosphatase, PTPase domain
- FERM domain
- Tyrosine-specific protein phosphatases domain
- Protein-tyrosine phosphatase, catalytic
- PH-like domain superfamily
- FERM/acyl-CoA-binding protein superfamily
- Protein-tyrosine phosphatase, non-receptor type-14/21
- Protein-tyrosine phosphatase, active site
- FERM, N-terminal
- FERM, C-terminal PH-like domain
- FERM conserved site
- FERM central domain
- Band 4.1 domain
- Protein-tyrosine phosphatase-like
- Ubiquitin-like domain superfamily
- FERM superfamily, second domain
- PTPN14/21, FERM domain C-lobe
- Protein-tyrosine phosphatase
- FERM central domain
- FERM N-terminal domain
- FERM C-terminal PH-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTPN14 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTPN14 as an antibody target. Whether an autoantibody or antibody against PTPN14 could matter depends on whether native PTPN14 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTPN14 is annotated at the cell surface, where native PTPN14 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label PTPN14 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...